2013
DOI: 10.1016/j.ijcard.2013.07.064
|View full text |Cite
|
Sign up to set email alerts
|

Treatment failure of low molecular weight heparin in diabetic patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 27 publications
(13 citation statements)
references
References 26 publications
0
12
0
Order By: Relevance
“…In fact in literature there are some reports of LMWH failure. 14,15 It is clearly too early to state that concomitant chronic use of DOAC for atrial fi brillation could play a protective role in patients with COVID-19 but evidences of the role of thromboembolism and the spread of the LMWH use in this context are in constant growth. Probably larger studies in the short term could confi rm or deny this hypothesis.…”
Section: Discussionmentioning
confidence: 99%
“…In fact in literature there are some reports of LMWH failure. 14,15 It is clearly too early to state that concomitant chronic use of DOAC for atrial fi brillation could play a protective role in patients with COVID-19 but evidences of the role of thromboembolism and the spread of the LMWH use in this context are in constant growth. Probably larger studies in the short term could confi rm or deny this hypothesis.…”
Section: Discussionmentioning
confidence: 99%
“…A diagnosis of heterozygous factor V of Leiden was made. [15][16][17][18][19][20][21][22][23] After 1 week of treatment, we performed another TEE, which showed persistence of the thrombotic mass in the LAA (Fig. 2B).…”
Section: Case Reportmentioning
confidence: 99%
“…2). Without knowledge of her other cardiovascular diseases, we concluded that the diagnosis of complete atrioventricular block was related to long-term complication of the radiotherapy [13][14][15][16]. It is recommended that all patients undergoing thoracic irradiation must carry out regularly cardiology check, to enable the detection and treatment of occurrence of cardiac conduction disturbances.…”
mentioning
confidence: 98%